doi: Bader S, Bhatti R, Mussa B, Abusanana S
Clinical context: The SURMOUNT-1 trial showed tirzepatide produced an average 22.5% body weight loss over 72 weeks
"In our future work, we will examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions," lead author Hamlet Gasoyan said
The lidocaine in the formula helps to minimize discomfort, making the procedure more comfortable
After two months of using 7 drops, three times a day, I reached 110 lbsno diet or workouts required
The body essentially decides that maintaining existing hair follicles is less important than preserving organ function and basic metabolic processes